Key Takeaways
- • Connecticut lawmakers advance Senate Bill 196 for the third consecutive year to restrict private equity ownership in healthcare, with the bill passing the Senate and moving to House consideration as of April 2026.
- • S.B. 196 would prohibit private equity investors from holding majority stakes in hospital main campus operations and ban their involvement in clinical decision-making, directly addressing three Connecticut hospitals currently under PE ownership.
- • The legislation explicitly prevents "sale-leaseback" transactions, a mechanism through which PE firms extract returns while burdening hospitals with rent obligations on their own facilities.
- • Public Health Committee co-chairs report sustained coordination with Governor Ned Lamont's office over recent months, with both executive and legislative proposals designed to complement each other rather than conflict as in previous failed attempts.
- • Prior legislative efforts failed despite bipartisan support due to misalignment between gubernatorial and legislative proposals; this session's collaborative approach represents a structural shift in negotiation strategy.
Summary
Connecticut lawmakers are making a renewed push to regulate private equity investment in healthcare through Senate Bill 196, marking the third consecutive legislative attempt to address the consequences of PE ownership at three state hospitals. The bill passed the Senate in late April 2026 and now faces House consideration. Unlike previous sessions, this year's effort reflects improved coordination between the legislative and executive branches, positioning the proposal with stronger momentum than before.
The core mechanisms of S.B. 196 target two specific PE strategies. First, the bill would prevent any private equity investor from owning a controlling stake in a hospital's main campus operations and would exclude PE firms from involvement in clinical decision-making. Second, it explicitly prohibits sale-leaseback transactions—a financial arrangement where hospitals sell their main campus buildings to real estate investment trusts and subsequently lease them back. This structure allows PE investors to generate investment returns while shifting long-term occupancy costs to the hospitals themselves, effectively draining resources from clinical operations.
The legislative-executive alignment distinguishes this year's effort from prior failures. Public Health Committee co-chair Senator Saud Anwar, D-South Windsor, stated that lawmakers have engaged in "robust conversations" with Governor Lamont's office over the preceding two months. While both branches have submitted separate proposals reflecting different regulatory philosophies, they are designed to be complementary rather than contradictory. Last year's session saw both sides introduce competing bills with different approaches, and the session ended before reconciliation could occur, with blame directed between branches. A spokesperson for Lamont reiterated the governor's commitment to curtailing private equity influence but stopped short of explicitly endorsing S.B. 196, suggesting ongoing negotiation on final bill language.
The failure of previous attempts, despite consistent bipartisan support, underscores the complexity of healthcare regulation when balancing investor protections against operational autonomy. With S.B. 196 now in the House pipeline and executive-legislative collaboration explicitly prioritized, stakeholders view this session as substantively different from prior legislative cycles on this issue.
The core mechanisms of S.B. 196 target two specific PE strategies. First, the bill would prevent any private equity investor from owning a controlling stake in a hospital's main campus operations and would exclude PE firms from involvement in clinical decision-making. Second, it explicitly prohibits sale-leaseback transactions—a financial arrangement where hospitals sell their main campus buildings to real estate investment trusts and subsequently lease them back. This structure allows PE investors to generate investment returns while shifting long-term occupancy costs to the hospitals themselves, effectively draining resources from clinical operations.
The legislative-executive alignment distinguishes this year's effort from prior failures. Public Health Committee co-chair Senator Saud Anwar, D-South Windsor, stated that lawmakers have engaged in "robust conversations" with Governor Lamont's office over the preceding two months. While both branches have submitted separate proposals reflecting different regulatory philosophies, they are designed to be complementary rather than contradictory. Last year's session saw both sides introduce competing bills with different approaches, and the session ended before reconciliation could occur, with blame directed between branches. A spokesperson for Lamont reiterated the governor's commitment to curtailing private equity influence but stopped short of explicitly endorsing S.B. 196, suggesting ongoing negotiation on final bill language.
The failure of previous attempts, despite consistent bipartisan support, underscores the complexity of healthcare regulation when balancing investor protections against operational autonomy. With S.B. 196 now in the House pipeline and executive-legislative collaboration explicitly prioritized, stakeholders view this session as substantively different from prior legislative cycles on this issue.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.